Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
HealthcareAdd-on
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Gilead to Acquire Tubulis to Expand ADC Oncology Platform
Announced
HealthcarePlatform
Deal Overview
Gilead Sciences has announced an acquisition of Tubulis to strengthen its oncology pipeline with an antibody-drug conjugate (ADC) and an expanded platform. The deal adds TUB-040, a NaPi2b-targeting ADC candidate for ovarian cancer and other solid tumors.
Gilead also described Tubulis as bringing an industry-leading ADC platform that includes its clinically validated Tubutecan linker-payload technology, along with a next-generation platform intended to expand Gilead’s ADC capabilities.
Key Details
- Transaction
- Gilead acquires Tubulis
- Deal Size
- Over $100M
Powered by Tentt
Source healthcare deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Seven-figure funding deal secures Swindon site acquisition for medical products firm
HealthcareAdd-on
Quvara Medical→Becton Dickinson
Apr 15, 2026
Indiana hospital signs LOI to join Parkview Health
HealthcareIndianaMerger
Parkview Health→Witham Health Services
Apr 15, 2026
What Surgery Partners’ vascular acquisition means for the industry
HealthcareTENNESSEEAdd-on
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra completes acquisition of AI firm Oxipit - AuntMinnie
HealthcareAdd-on
Sectra→Oxipit
Apr 15, 2026